German chemical company BASF is currently going after Norway’s Pronova BioPharma, a company that manufactures the active ingredient for GlaxoSmithKline's popular omega-3 fish oil drug, Lovaza. This week, BASF extended its EUR 664 million-offer to buy the shares of Pronova to 18 January 2013.
"The intended acquisition will significantly strengthen our position in the fast-growing and highly profitable market for omega-3 fatty acids. We want to combine the global market reach and experience of BASF with the know-how of Pronova in omega-3 fatty acids," said Michael Heinz, a BASF board member.
The Norwegian Pelagic Fishing Course in Week 18 Norway
Still low activity in the sandpiper fishery and modest catches of other species, despite some larger catches of coal mullet.
Blue whiting:
17,645 tonnes registered from 12 different boats. Large p...
Copyright 1995 - 2024 Seafood Media Group Ltd.| All Rights Reserved. DISCLAIMER